SND1 and ovarian carcinoma: Moreover, recent studies have also revealed that inhibition of SND1 promoted cisplatin-induced cell death in other cancer cells including bladder [15] and ovarian cancer cells [28], where the chemotherapy efficacy is generally low [29, 30], conferring the reversed chemoresistance.